INVESTOR ALERT: Brower Piven Encourages Shareholders Who

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 From Investment in Valeant Pharmaceuticals International, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- VRX

STEVENSON, Md., Nov. 18, 2015 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (“Valeant” or the “Company”) common stock during the period between February 28, 2014 and October 21, 2015, inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation have until December 21, 2015 to seek appointment as lead plaintiff.

If you have suffered a loss from investment in Valeant common stock purchased on or after February 28, 2014 and held through the revelation of negative information during and/or at the end of the Class Period, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html .  You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616.  No class has yet been certified in the above action.  Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.

If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court.  The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action.  The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Company common stock during the Class Period.  Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Valeant had a relationship with a network of specialty pharmacies used to boost Valeant’s sales of its high-priced drugs which left Valeant vulnerable to increased regulatory risks, that the Company faced the risk of scrutiny over its price increases for certain drugs and was under government scrutiny for its financial assistance programs for patients, pricing decisions and the distribution of its products, that Valeant’s financial performance would be negatively impacted without using specialty pharmacies, and that Valeant’s true relationship with specialty pharmacy Philidor was that Valeant controlled Philidor.

According to the complaint, following a September 28, 2015 Congressional Committee letter addressing that the Company failed to adequately explain substantial price increases for cost of drugs recently purchased by the Company; October 5, 2015 media coverage of the Company’s pricing tactics, the October 14, 2015 disclosure that Massachusetts and New York had issued subpoenas relating primarily to patient assistance programs and pricing decisions; the October 19, 2015 Company disclosure that the Company was considering the spinoff of a portfolio of certain drugs, discussing Valeant’s relationship with specialty pharmacies, including Philidor, and refusing to discuss subpoenas from federal prosecutors; an October 19, 2015 New York Times article addressing the Company’s drug pricing tactics; and an October 21, 2015 Citron Research report providing greater detail of, among other things, the Company’s drug sales and pricing schemes, the value of Valeant shares declined significantly.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.  If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice.  You need take no action at this time to be a member of the class.

Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 / hoffman@browerpiven.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 47

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 64

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
Main Capital Partners Backs TaskRay: Salesforce Expansion

Updated Category News Views 18

Investing in Transformation Main Capital Partners has thrown in with TaskRay, joining hands with Cloud Coach and JustOn to shake up customer delivery on Salesforce. These three are cooking up an ambitious AI-driven platform that's gunning to streamline from project management to financial operations. Main's stepping into this mix with a mindset that aligns with over 800...

Continue Reading
Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 15

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 398

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 35

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 136

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 109

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 0

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 307

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading

Top 5 Most Recently Viewed Articles

Future of Super Abrasives in Precision Engineering Markets

Updated Category News Views 96

Projected Growth of the Super Abrasives Market The global super abrasives market is on an exceptional growth trajectory, aiming to surpass a valuation of US$ 11.0 billion by 2032 from US$ 7.0 billion in 2023. This impressive growth, forecasted at an estimated CAGR of 6.5% from 2024 to 2032, reflects the diverse opportunities that lie ahead. Industry Drivers and...

Continue Reading
PSE&G Gains Top Spot in JD Power Rankings: What's Behind the Success?

Updated Category News Views 236

PSE&G Climbs To Number One Spot: What's Changed? Public Service Electric & Gas (PSE&G), New Jersey's largest utility, just snagged the top spot for business electric customer satisfaction in the East, according to JD Power's latest study. This is an upgrade from their second place showing in 2025. But how did they leapfrog their competition to reach the pinnacle? The...

Continue Reading
Hilbert Group Enhances Portfolio with Investment in CCD Token

Updated Category News Views 160

Hilbert Group Broadens Its Horizon with Strategic Investment Hilbert Group, a renowned global digital asset investment firm, is making waves in the blockchain space with its latest strategic long-term investment in CCD, the native token of Concordium, a cutting-edge PayFi blockchain designed for institutional-grade payments. A Landmark Move Beyond Bitcoin and Ethereum...

Continue Reading
Explore the Dynamic Features of the 2026 Ford Escape Now

Updated Category News Views 272

Discover the Exciting Evolution of the 2026 Ford Escape The all-new 2026 Ford Escape brings significant improvements in design, technology, and performance that will surely captivate new car buyers. Akins Ford, a premier Ford dealership near Atlanta, is excited to offer an in-depth look at what makes this compact SUV a standout choice for drivers. Key Design Enhancements...

Continue Reading
Forestar Group Navigates Challenges as Stock Hits New Low

Updated Category News Views 117

Forestar Group’s Stock Hits a 52-Week Low Forestar Group Inc. (NYSE: FOR) is experiencing a tough time in the current market environment. The company's shares have recently fallen to a 52-week low of $25.27. This decline highlights the struggles faced by the real estate and land development sector over the past year, contributing to a substantial 24.6% decrease in their...

Continue Reading